Total Payments
$329,209
2024 Payments
$89,041
Companies
56
Transactions
1,631
Medicare Patients
812
Medicare Billing
$124,486
Payment Breakdown by Category
Other$235,693 (71.6%)
Food & Beverage$33,732 (10.2%)
Consulting$32,264 (9.8%)
Travel$19,604 (6.0%)
Research$7,476 (2.3%)
Education$439.71 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $225,875 | 79 | 68.6% |
| Food and Beverage | $33,732 | 1,409 | 10.2% |
| Consulting Fee | $32,264 | 13 | 9.8% |
| Travel and Lodging | $19,604 | 117 | 6.0% |
| Honoraria | $9,818 | 5 | 3.0% |
| Unspecified | $7,476 | 1 | 2.3% |
| Education | $439.71 | 7 | 0.1% |
Payments by Type
General
$321,733
1,630 transactions
Research
$7,476
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $170,147 | 385 | $0 (2024) |
| Gilead Sciences, Inc. | $116,680 | 328 | $0 (2024) |
| Theratechnologies Inc. | $25,852 | 85 | $0 (2024) |
| Janssen Biotech, Inc. | $2,068 | 126 | $0 (2023) |
| Novo Nordisk Inc | $1,526 | 83 | $0 (2023) |
| ABBVIE INC. | $1,476 | 77 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,113 | 75 | $0 (2024) |
| Novo Nordisk AS | $1,016 | 4 | $0 (2017) |
| Amgen Inc. | $875.22 | 62 | $0 (2024) |
| Lilly USA, LLC | $784.76 | 52 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $89,041 | 195 | ViiV Healthcare Company ($47,952) |
| 2023 | $124,766 | 265 | ViiV Healthcare Company ($88,803) |
| 2022 | $39,040 | 197 | ViiV Healthcare Company ($26,064) |
| 2021 | $10,371 | 186 | Gilead Sciences, Inc. ($6,588) |
| 2020 | $9,471 | 168 | Gilead Sciences, Inc. ($5,348) |
| 2019 | $22,764 | 193 | Gilead Sciences, Inc. ($19,590) |
| 2018 | $24,654 | 227 | Gilead Sciences, Inc. ($21,765) |
| 2017 | $9,102 | 200 | ViiV Healthcare Company ($5,247) |
All Payment Transactions
1,631 individual payment records from CMS Open Payments — Page 1 of 66
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $6.47 | General |
| Category: HIV | ||||||
| 12/17/2024 | Gilead Sciences, Inc. | Sunlenca (Drug) | Travel and Lodging | In-kind items and services | $76.90 | General |
| Category: HIV | ||||||
| 12/17/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: VIROLOGY | ||||||
| 12/13/2024 | Gilead Sciences, Inc. | Sunlenca (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,190.00 | General |
| Category: HIV | ||||||
| 12/12/2024 | Gilead Sciences, Inc. | Sunlenca (Drug) | Food and Beverage | In-kind items and services | $32.10 | General |
| Category: HIV | ||||||
| 12/11/2024 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 12/10/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $490.00 | General |
| Category: HIV | ||||||
| 12/10/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: HIV | ||||||
| 12/09/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: HIV | ||||||
| 12/03/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: VACCINE | ||||||
| 12/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $32.88 | General |
| 11/27/2024 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $18.58 | General |
| Category: Allergy/Immunology | ||||||
| 11/22/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $8.78 | General |
| Category: HIV | ||||||
| 11/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $5.49 | General |
| 11/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $6.38 | General |
| 11/19/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 11/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $88.22 | General |
| 11/13/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $29.53 | General |
| Category: HIV | ||||||
| 11/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $9.76 | General |
| 11/06/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: HIV | ||||||
| 11/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Cardio-renal | ||||||
| 10/30/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $107.95 | General |
| Category: HIV | ||||||
| 10/30/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/28/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $38.10 | General |
| Category: HIV | ||||||
| 10/28/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $6.22 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes with and without Ibalizumab in a Real-World Setting: United States (PROMISE-US) | Theratechnologies Inc. | $7,476 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 183 | 360 | $52,521 | $26,374 |
| 2022 | 6 | 162 | 356 | $52,444 | $32,117 |
| 2021 | 7 | 196 | 365 | $48,522 | $31,924 |
| 2020 | 10 | 271 | 552 | $61,335 | $34,072 |
Total Patients
812
Total Services
1,633
Medicare Billing
$124,486
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 100 | 239 | $39,392 | $20,324 | 51.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 34 | $7,656 | $3,654 | 47.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 30 | $4,341 | $1,916 | 44.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 32 | 57 | $1,132 | $478.80 | 42.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 69 | 214 | $29,268 | $18,556 | 63.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 44 | 91 | $18,772 | $11,434 | 60.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 12 | 12 | $3,000 | $1,545 | 51.5% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 14 | 14 | $280.00 | $254.01 | 90.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 12 | 12 | $240.00 | $214.14 | 89.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 11 | 13 | $884.00 | $113.21 | 12.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 82 | 193 | $25,992 | $17,534 | 67.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 44 | 89 | $17,548 | $12,017 | 68.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 12 | 12 | $3,000 | $1,582 | 52.7% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 15 | 15 | $300.00 | $273.75 | 91.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 13 | 13 | $260.00 | $237.25 | 91.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 14 | 17 | $1,156 | $201.28 | 17.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 16 | 26 | $266.00 | $78.00 | 29.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 95 | 317 | $39,558 | $23,360 | 59.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 39 | 60 | $11,847 | $5,841 | 49.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 27 | 34 | $3,070 | $1,783 | 58.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 11 | 11 | $2,750 | $1,260 | 45.8% |
| 90653 | Vaccine for influenza for injection into muscle | Office | 2020 | 11 | 11 | $660.00 | $652.45 | 98.9% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 29 | 49 | $1,470 | $480.27 | 32.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 17 | 17 | $575.00 | $279.38 | 48.6% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2020 | 11 | 11 | $220.00 | $196.04 | 89.1% |
About Dr. Edward Braun, MD
Dr. Edward Braun, MD is a Family Medicine healthcare provider based in St Petersburg, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558330639.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Braun, MD has received a total of $329,209 in payments from pharmaceutical and medical device companies, with $89,041 received in 2024. These payments were reported across 1,631 transactions from 56 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($225,875).
As a Medicare-enrolled provider, Braun has provided services to 812 Medicare beneficiaries, totaling 1,633 services with total Medicare billing of $124,486. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location St Petersburg, FL
- Active Since 03/14/2006
- Last Updated 11/20/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1558330639
Products in Payments
- APRETUDE (Biological) $106,502
- DOVATO (Drug) $47,571
- Descovy (Drug) $42,533
- Truvada (Drug) $32,126
- Biktarvy (Drug) $31,734
- TROGARZO (Drug) $21,874
- TIVICAY (Drug) $5,147
- Sunlenca (Drug) $3,299
- Ozempic (Drug) $1,550
- EGRIFTA (Drug) $1,477
- SYMTUZA (Drug) $1,374
- CABENUVA (Biological) $846.57
- PREZCOBIX (Drug) $579.42
- Vascepa (Drug) $512.68
- Symtuza (Drug) $447.03
- ISENTRESS (Drug) $418.22
- ELIQUIS (Drug) $396.29
- Aimovig (Biological) $386.66
- Otezla (Drug) $361.95
- TRIUMEQ (Drug) $360.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in St Petersburg
Dr. Roxana Stoici, Md, MD
Family Medicine — Payments: $228,936
Family Medicine $228,936
Dr. Robert Wallace, Md, MD
Family Medicine — Payments: $151,311
Family Medicine $151,311
Dr. Frederic Guerrier, M.d, M.D
Family Medicine — Payments: $45,706
Family Medicine $45,706
Dr. Gigi Lefebvre, Md, MD
Family Medicine — Payments: $15,802
Family Medicine $15,802
Dr. Daniel Eckstein, M.d, M.D
Family Medicine — Payments: $10,665
Family Medicine $10,665
Dr. Kunal Amin, Md, MD
Family Medicine — Payments: $10,623
Family Medicine $10,623